$11.78 Million in Sales Expected for TransAct Technologies Incorporated (NASDAQ:TACT) This Quarter

Brokerages expect TransAct Technologies Incorporated (NASDAQ:TACTGet Rating) to announce sales of $11.78 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for TransAct Technologies’ earnings, with the highest sales estimate coming in at $12.78 million and the lowest estimate coming in at $10.77 million. TransAct Technologies reported sales of $9.33 million in the same quarter last year, which indicates a positive year over year growth rate of 26.3%. The firm is expected to report its next earnings report on Monday, January 1st.

On average, analysts expect that TransAct Technologies will report full-year sales of $50.59 million for the current financial year, with estimates ranging from $46.22 million to $54.96 million. For the next financial year, analysts forecast that the firm will post sales of $69.24 million, with estimates ranging from $61.24 million to $77.25 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for TransAct Technologies.

TransAct Technologies (NASDAQ:TACTGet Rating) last announced its quarterly earnings results on Wednesday, March 9th. The technology company reported ($0.19) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.04. TransAct Technologies had a negative return on equity of 26.52% and a negative net margin of 14.59%. The firm had revenue of $11.12 million for the quarter, compared to analyst estimates of $10.24 million. During the same period last year, the firm posted ($0.22) earnings per share.

Several analysts recently weighed in on TACT shares. Craig Hallum reduced their price objective on shares of TransAct Technologies from $20.00 to $12.00 in a research note on Thursday, March 10th. StockNews.com began coverage on TransAct Technologies in a research report on Friday, May 13th. They issued a “hold” rating on the stock. Zacks Investment Research downgraded TransAct Technologies from a “hold” rating to a “sell” rating in a research report on Tuesday. Roth Capital reduced their target price on TransAct Technologies from $21.00 to $14.00 in a report on Thursday, March 10th. Finally, Barrington Research decreased their target price on shares of TransAct Technologies from $20.00 to $15.00 in a research report on Thursday, March 10th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. According to MarketBeat, TransAct Technologies currently has an average rating of “Hold” and an average price target of $13.67.

Shares of NASDAQ TACT opened at $4.92 on Wednesday. The firm has a 50 day moving average price of $6.99 and a two-hundred day moving average price of $9.21. The stock has a market cap of $48.76 million, a P/E ratio of -7.70 and a beta of 1.85. TransAct Technologies has a 52-week low of $4.76 and a 52-week high of $17.18.

Large investors have recently made changes to their positions in the company. Dimensional Fund Advisors LP grew its stake in TransAct Technologies by 0.4% during the third quarter. Dimensional Fund Advisors LP now owns 264,934 shares of the technology company’s stock worth $3,683,000 after purchasing an additional 944 shares during the period. Morgan Stanley boosted its holdings in shares of TransAct Technologies by 6.6% during the 2nd quarter. Morgan Stanley now owns 18,266 shares of the technology company’s stock worth $251,000 after buying an additional 1,134 shares in the last quarter. BlackRock Inc. grew its position in shares of TransAct Technologies by 0.5% during the 4th quarter. BlackRock Inc. now owns 242,698 shares of the technology company’s stock worth $2,646,000 after buying an additional 1,175 shares during the period. Barclays PLC increased its stake in shares of TransAct Technologies by 238.0% in the 3rd quarter. Barclays PLC now owns 2,552 shares of the technology company’s stock valued at $35,000 after acquiring an additional 1,797 shares in the last quarter. Finally, Perritt Capital Management Inc. lifted its position in shares of TransAct Technologies by 4.3% during the 3rd quarter. Perritt Capital Management Inc. now owns 67,500 shares of the technology company’s stock valued at $938,000 after acquiring an additional 2,778 shares during the period. 74.60% of the stock is currently owned by institutional investors.

About TransAct Technologies (Get Rating)

TransAct Technologies Incorporated designs, develops, and markets transaction-based and specialty printers and terminals in the United States and internationally. Its thermal printers and terminals to generates labels, coupons, and transaction records, such as receipts, tickets, and other documents, as well as printed logging and plotting of data.

Recommended Stories

Get a free copy of the Zacks research report on TransAct Technologies (TACT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for TransAct Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransAct Technologies and related companies with MarketBeat.com's FREE daily email newsletter.